Alzheimer

An new amazing hope .."Biogen" - a promising drug for the treatment of Alzheimer's... It is well known that the incidence of Alzheimer's


disease leads to memory loss, inability to concentrate,
but the study may be a precursor to Alzheimer's patients: it is to reach a first drug slows Alzheimer's symptoms.

It is well known that the incidence of Alzheimer's disease leads to memory loss, inability to concentrate, but the study may be a precursor to Alzheimer's patients: it is to reach a first drug slows Alzheimer's symptoms.

Limited study showed that a promising experimental drug development company, "Biogen ADIC" became the first cure for Alzheimer concrete slow cognitive decline extent, and reduces what is believed to be toxic patches destroy the brain in patients with early and middle stages of the disease.

There are about 15 million Alzheimer's patients in the world, it is expected that the number will reach 75 million by 2030, if not reached effective treatment for the disease, which costs human billions of dollars annually.

Analysts say that any effective treatment for Alzheimer's drugs would be more profitable in the world, but before the drug Biogen years of tests and will not reach the market before 2020, if everything went well.
Biogen Inc. and entered a field already full of costly failures incurred by companies such as Pfizer and Eli Lilly & Co. And place each of the two Lilly and Roche Holding AG experiments on drugs work in the same way a drug Biogen, the inhibition of protein "Omilid beta" which causes the formation of toxic spots in the brain, theoretically agreed that the underlying cause of the disease that destroys the brain.
 He says Alfred Sandrock large medical experts in Biogen This is the first time that an experimental drug to achieve a significant reduction in patches Alamilid and also slow the process of deterioration that affects the patient's brain.

Included experiment, which took place on the drug Biogen 166 people divided into five groups, got four sets of them on different doses of the drug and the fifth group has dealt with placebo.

Data provided by the company showed that the drug Biogen has reduced Alomilid. This reduction was more pronounced the higher the dose and the longer duration of treatment.

The researchers observed through X to measure Alomilid in six regions of the brain that those patches level almost unchanged with placebo, which lasted 26 weeks and 54 weeks.

Patients who were treated with either three or six or ten milligrams of the drug per kilogram of body weight has been reduced to patches have space, in the treatment lasted 26 weeks and was shrinkage increases with increasing dose. Rather, the decline was the largest patches toxic in patients after treatment at a dose of three milligrams and six milligrams for 54 weeks.
Find out more about How you can Improve Mind Memory and Mind Energy for ages and The
advantages of Mind Exercise and what about the Dietary supplements